WS #3007

The data dump reveals a complex interplay of geopolitical and economic signals, with the Strait of Hormuz situation dominating market-moving narratives. Iran's announcement that non-hostile vessels can pass through the Strait (corroborated by multiple sources including Al Jazeera, MB Daily News, and Geobarta) provides a de-escalatory signal that could ease immediate oil supply fears, potentially pressuring crude prices downward. However, this is countered by escalatory developments: Ukraine's reported attack on Russian oil infrastructure near Saint Petersburg and a Baltic oil depot, alongside an airstrike on Shi'ite forces in Anbar, suggest ongoing regional disruptions that could support oil prices. The UK's offer to host a summit to reopen the Strait adds diplomatic momentum to de-escalation efforts. In corporate developments, Merck's potential $6 billion biotech deal to boost its cancer drug pipeline (reported by FT) signals aggressive expansion in oncology, potentially impacting MRK and biotech peers. Fractyl Health's 21% after-hours jump on positive weight-maintenance data reinforces bullish sentiment in the weight-loss drug sector, contrasting with earlier bearish pressures. Meta's performance-linked stock grants to executives, as per SEC filings, indicate internal confidence that could stabilize META stock following recent legal setbacks. Economic data shows UK inflation remaining at 3% year-over-year in February, matching forecasts, but core CPI rose slightly above expectations to 3.2%, suggesting persistent underlying price pressures that could delay Bank of England rate cuts. The Philippines declaring a national energy emergency and Philippine Airlines warning of potential fuel rationing highlight downstream impacts of oil market volatility, affecting airlines and emerging market equities. Thailand abandoning its diesel price cap underscores fiscal strain from rising crude costs.